Abnormal glutamate transport function has also been reported in mutant amyloid precursor protein transgenic mice [87], and altered ratio between GFAP and GLT1 in the cerebral cortex in AD [107]. This evidence concerns the gene SLC1A2 and Alzheimer disease.